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In childhood and adolescence, pancreatic neoplasms are generally treated by resection, whereas the
management of pancreatitis is predominantly nonoperative. Autoimmune pancreatitis (AIP) is a form of
chronic pancreatitis that frequently presents as a mass and responds to corticosteroids. When serologic
tests are not diagnostic, a biopsy may spare a child a pancreatic resection. We report the case of a child
who presented with a 3 cm mass in the head of the pancreas with a double duct sign who had AIP.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Distinguishing pancreatitis from a pancreatic tumor in a child
can be difﬁcult. Tumors are treated with resectionwhereas primary
treatment for childhood pancreatitis is nonoperative. We report a
child who presented with a mass in the head of the pancreas with a
double duct sign. Percutaneous biopsy of this mass was performed
after endoscopic retrograde cholangiopancreatogram (ERCP)
brushing was inconclusive and serologic tests unremarkable. The
diagnosis of autoimmune pancreatitis (AIP) was conﬁrmed and the
symptoms and radiographic ﬁndings responded to steroid therapy.
This case is presented to emphasize the need for additional testing
to be considered prior to pancreatic resection for a mass in a child.
1. Case report
A seven year old boy presented with epigastric pain that initially
responded to H2 blockers. He developed jaundice that cleared
spontaneously and then returned. A CT scan of the abdomen
revealed a 3 cm mass in the head of the pancreas (Fig. 1). He was
admitted to the hospital for further evaluation. Pertinent laboratory
tests were AST 83 nU/L, ALT 93 U/L, alkaline phosphatase 824 U/L,
amylase 299 U/L, lipase 3881 U/L, total bilirubin 2.2 mg/dl and BUN
51 mg/dl. Cystic ﬁbrosis DNA analysis was negative. Viral panel was
negative and Immunoglobulin levels and subclasses were normal as
well as CEA and CA19-9 levels. Immunoglobulins including IgG 4spital, 1150 N. 35 Ave., Suite
c. This is an open access article undesubclass were normal. Magnetic resonance cholangiopancreato-
gram (MRCP) revealed an ill deﬁned 2.2  3.3  4.3 cm isointense
mass in the head of the pancreas causing obstruction of the com-
mon bile duct and partial obstruction of the pancreatic duct (Fig. 2).
The patient had an ERCP with brushing of the common bile duct
and stent placement. The imagingwas not characteristic for the rare
pancreatic neoplasms seen in children. Common bile duct brushing
showed focal atypia. Over one month the patient clinically
improved, but themass remained. A CTguided biopsy of the head of
the pancreas revealed duct-centric pancreatitis, also referred to as
type II autoimmune pancreatitis or idiopathic duct destructive
pancreatitis. He was treated with prednisolone for one month and
his stent was removed ﬁve weeks after placement. Laboratory tests
normalized and repeatMRCP twoweeks after discontinuation of his
steroids showed resolution of the pancreatic mass and ductal
dilatation andminimal residual prominence of the common hepatic
duct. He remains asymptomatic three years after discontinuation of
steroids.2. Discussion
Pediatric pancreatic neoplasms include pancreatoblastomas,
cystic lesions, solid pseudopapillary tumors, islet cell tumors, cys-
tadenomas and metastatic lesions. Even large pediatric centers
have limited experience with these lesions. The complication rate
for pancreatic resection is signiﬁcant with a 28% rate reported in a
series of pediatric neoplasms. Not mentioned was how many
patients had biopsy before resection or whether any patients hadr the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. CT mass in the head of the pancreas.
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pancreatic neoplasms, primary resection without biopsy is the
current procedure [2]. Of adult patients who had pan-
creaticoduodenectomies for periampullary lesions, 10% were found
not to have malignancies [3]. A multicenter study of patients
undergoing pancreaticoduodenectomy for presumed malignant
disease found the discriminatory value of preoperative imaging to
be insufﬁcient since 6.6% of resected specimens had benign disease
[4]. One of the ﬁrst reports of autoimmune pancreatitis in a child
was diagnosed after pancreaticoduodenectomy [5].
Autoimmune pancreatitis is awell described entity in adults and
can present as a mass [6]. Sporadic case reports of AIP in children
since 2006 suggest diagnosis may be more difﬁcult than in adultsFig. 2. MRCP with obstruction of the common bile duct and partial obstruction of the
pancreatic duct.[7e11]. IgG4 testing ishelpful inmaking thediagnosiswhen the level
is elevated. Serologic testing for anti-tissue antibodies and IgG4was
performed on 129 childrenwith pancreatitis and AIP was suspected
in6patients [12]. In a recent reviewof 211 childrenwithpancreatitis,
idiopathic was still the highest category (31%). Autoimmune disease
occurred in 2.8% and inﬂammatory bowel disease in 1.9% but none
were diagnosed with AIP and no pathology was discussed [13].
Classically, causes of pediatric pancreatitis are divided into
congenital anomalies, trauma, infection and idiopathic [14]. In a
review of 32 children from 1981 to 2005 with chronic pancreatitis,
prior to the description of AIP, 10 were diagnosed as idiopathic
ﬁbrosing pancreatitis. Fifteen of the patients were treated with
pancreatic resection at an average of three years after the presen-
tation but no data was presented about the pathology [15]. Suc-
cessful treatment of ﬁbrosing pancreatitis with steroids in three
children was described by El-Matary et al. Biopsy of one showed
lymphocytic and plasma cell inﬁltration [16]. Blejter et al. described
an adolescent case of AIP diagnosed at laparotomy performed
because of a mass in the head of the pancreas. The patient’s IgG4
level was normal and autoimmune serologies were negative.
Pathology revealed periductal lymphoplasmacytic inﬁltration. In
spite of transcystic drainage, the patient did not improve until ste-
roids were started [7]. An additional report of AIP in three children
supports the idea that ﬁbrosing pancreatitis is actually AIP and
further describes the variation in clinical presentation in children
versus adults [11]. A fourteenyear old girlwith an enlarged pancreas
and duct had normal IgG4 levels [10]. IgG4 staining of ERCP speci-
mens showshigh speciﬁcity for AIP and canbe particularly helpful in
the case of normal serum IgG4 [17]. Improved diagnostic accuracy of
AIP on core needle biopsy was foundwhen presence of granulocytic
epithelial lesions was included as a positive criteria [18].
Because of the increased frequency of AIP in adults compared to
children, there are more reports detailing the serologic markers and
histologic features necessary for a diagnosis of AIP. After reviewing
29 patients whomet established diagnostic criteria, theMayo Clinic
group recommended including response to steroids as an addi-
tional diagnostic criteria which identiﬁed an additional 20 patients
with AIP [19]. Pain and jaundice were the most common symptoms
in a large series of adult patients. Radiographic ﬁndings of a mass,
bile duct strictures or peripancreatic vascular complications can be
seen. Steroids were the mainstay of therapy but relapse can occur
[20]. Twenty two adult patients were identiﬁed over a thirteen year
period in England, treated with steroids with 23% requiring further
immunosuppression for treatment of relapses [21]. Given the con-
cerns about missing a malignancy, the authors emphasized the
necessity of strict adherence to diagnostic criteria.
3. Conclusion
The performance of a percutaneous biopsy should be given
serious consideration in any child presenting with pancreatitis in
association with a mass. In this clinical setting, it is imperative to
distinguish a neoplastic process from an inﬂammatory one. The
diagnosis of AIP may be delayed or overlooked in children because
serologic markers are frequently unreliable. Tissue sampling by
percutaneous biopsy or brushings obtained from ERCP can differ-
entiate AIP from invasive neoplasm in these children. The response
of many patients with ﬁbrosing pancreatitis to steroids raises the
possibility these children were actually suffering from AIP. It bears
emphasizing that a history of autoimmune disease or inﬂammatory
bowel disease even when accompanied by normal serum IgG4
levels, increases the likelihood the true underlying pathologic
process is AIP.
The accurate diagnosis of a child who presents with both
pancreatitis and a pancreatic mass is of extreme clinical importance
J. Long et al. / J Ped Surg Case Reports 3 (2015) 111e113 113as it may obviate the need for surgical intervention. The clinician
must remain aware that some children presentingwith a pancreatic
mass and pancreatitis will be suffering from AIP. In this group, a
course of steroid therapy may prevent the development of diabetes
resulting from chronic untreated pancreatitis. Another salubrious
effect of steroid treatment in AIP is to help preclude the develop-
ment of a pancreatic duct stricture, which can result in chronic pain
or the need for surgical correction.References
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